|[August 15, 2014]
Pragma Pharmaceuticals Announces Re-Launch of Moxatag®
NEW YORK --(Business Wire)--
Pragma Pharmaceuticals is pleased to announce that it is re-launching
Moxatag® 775 mg (amoxicillin extended-release tablets), the
only once-a-day amoxicillin.
(Photo: Business Wire)
Pragma acquired Moxatag from Shionogi Inc. in March 2014 and has been
working to make the product available in time for the upcoming cold and
A Pragma spokesperson says, "Amoxicillin is the gold standard in
treating strep pharyngitis. Simplifying the dosing regimen is a no
brainer. Greater convenience to help patient compliance is key to
ensuring effective antibiotic therapy."
Fera Pharmaceuticals has been selected to manage the sales and marketing
of Moxatag for Pragma.
Moxatag, the first and only once-a-day amoxicillin, is indicated for the
treatment of tonsillitis and/or pharyngitis secondary to Streptococcus
pyogenes (S. pyogenes) in adult and pediatric patients 12 years of
age or older. For more information visit www.moxatag.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140815005433/en/
[ Back To Technology News's Homepage ]